@article{060fba1784e54e3fac99186edb78556b,
title = "Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project",
abstract = "Chronic hepatitis C virus (HCV) infection is a global public health issue, which is associated with high rates of morbidity and mortality. The development of direct acting antivirals (DAAs) has transformed treatment: they offer us highly-effective therapy with superior tolerability compared to interferon-containing regimens. In 2016, the World Health Organization (WHO) therefore adopted several ambitious viral hepatitis elimination targets, aiming for a 90% reduction in new infections and a 65% reduction in mortality by 2030. The ultimate goal is to eliminate HCV completely. It is reasonable that these goals may be achieved in the Netherlands due to the low prevalence of chronic HCV, the availability of DAAs, and excellent healthcare infrastructure. This paper describes a national effort to curtail the HCV epidemic in the Netherlands through an HCV retrieval and linkage to care project (CELINE: Hepatitis C Elimination in the Netherlands).",
keywords = "HCV, chronic hepatitis C, elimination, retrieval, AMSTERDAM, OUTCOMES, DECLINE",
author = "{van Dijk}, M. and Kracht, {P. A. M.} and Arends, {J. E.} and H. Blokzijl and Burger, {D. M.} and {van Erpecum}, {K. J.} and {van Hoek}, B. and {de Knegt}, {R. J.} and D. Posthouwer and D. Ramsoekh and Rijnders, {B. J. A.} and J. Schinkel and Willemse, {S. B.} and {van der Valk}, M. and Drenth, {J. P. H.} and {HepNed Study Group}",
note = "Funding Information: In view of the WHO viral hepatitis elimination targets, recent international developments, and encouraging pilot projects, HepNed designed a strategy that facilitates a nationwide retrieval project: “Hepatitis C Elimination in the Netherlands” (CELINE). CELINE aims to tackle the HCV problem by identifying lost to follow-up chronic HCV patients and giving them appropriate care according to the latest evidence-based guidelines (the online-only available Dutch HCV guidelines32 and/or European Association for the Study of Liver (EASL) Recommendations33). It is a three-year program which started in 2018. CELINE is financially supported through the HCV SCALE program (Screening Access and Linkage to CarE ) from Gilead Sciences. Publisher Copyright: {\textcopyright} MacChain. All rights reserved.",
year = "2019",
month = may,
language = "English",
volume = "77",
pages = "131--138",
journal = "Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "Van Zuiden Communications",
number = "4",
}